FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
1-Year Return
23.12%
This Quarter Return
+18.86%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$16.1B
AUM Growth
+$2B
(+14%)
Cap. Flow
+$25.6M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
31.86%
Holding
165
New
37
Increased
28
Reduced
33
Closed
28
Top Buys
| 1 |
Aramark
ARMK
|
$424M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
$362M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$351M |
| 4 |
RTX Corp
RTX
|
$325M |
| 5 |
Broadcom
AVGO
|
$273M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$498M |
| 2 |
AbbVie
ABBV
|
$332M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$299M |
| 4 |
Palo Alto Networks
PANW
|
$217M |
| 5 |
Bristol-Myers Squibb
BMY
|
$217M |
Sector Composition
| 1 | Healthcare | 39.5% |
| 2 | Communication Services | 13.65% |
| 3 | Financials | 10.37% |
| 4 | Technology | 10.17% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KSU
51
DELISTED
Kansas City Southern
KSU
| $72.3M | 0.44% |
354,400
-39,600
| -10% | -$8.08M |
|
52
Equifax
EFX
$30.8B
| $71.5M | 0.43% |
370,684
-25,800
| -7% | -$4.98M |
|
|
KRTX
53
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $71.1M | 0.43% |
700,000
| – | – |
|
54
FibroGen
FGEN
$48.9M
| $70.5M | 0.42% |
76,000
+2,000
| +3% | +$1.85M |
|
55
BioAtla
BCAB
$31.5M
| $66.9M | 0.4% |
+1,967,060
| New | +$66.9M |
|
56
Generation Bio
GBIO
$40.3M
| $64.3M | 0.39% |
226,882
+14,819
| +7% | +$4.2M |
|
|
ARNA
57
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $57.6M | 0.35% |
750,000
+120,114
| +19% | +$9.23M |
|
58
Pacific Biosciences
PACB
$381M
| $54.5M | 0.33% |
2,100,000
-1,963,770
| -48% | -$50.9M |
|
59
Cytokinetics
CYTK
$6.34B
| $49.9M | 0.3% |
2,400,000
+250,000
| +12% | +$5.2M |
|
60
Protagonist Therapeutics
PTGX
$3.77B
| $48.9M | 0.29% |
2,425,000
-325,000
| -12% | -$6.55M |
|
61
Alnylam Pharmaceuticals
ALNY
$59.2B
| $45.5M | 0.27% |
350,000
-850,000
| -71% | -$110M |
|
|
ZGNX
62
DELISTED
Zogenix, Inc.
ZGNX
| $45M | 0.27% |
2,250,000
| – | – |
|
|
CLGX
63
DELISTED
Corelogic, Inc.
CLGX
| $44.4M | 0.27% |
574,028
+229,028
| +66% | +$17.7M |
|
64
Agios Pharmaceuticals
AGIO
$2.09B
| $43.3M | 0.26% |
1,000,000
-83,429
| -8% | -$3.61M |
|
65
Ionis Pharmaceuticals
IONS
$9.76B
| $42.4M | 0.26% |
+750,000
| New | +$42.4M |
|
66
Annexon
ANNX
$238M
| $39M | 0.23% |
1,557,261
-100,000
| -6% | -$2.5M |
|
|
RDUS
67
DELISTED
Radius Health, Inc.
RDUS
| $37.6M | 0.23% |
2,107,400
| – | – |
|
|
TVRD
68
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
| $37.3M | 0.22% |
68,472
+5,972
| +10% | +$3.25M |
|
69
Lantheus
LNTH
$3.72B
| $35.7M | 0.22% |
2,650,000
| – | – |
|
70
Zymeworks
ZYME
$1.14B
| $35.4M | 0.21% |
750,000
-102,200
| -12% | -$4.83M |
|
71
Krystal Biotech
KRYS
$4.35B
| $31.5M | 0.19% |
525,000
+50,000
| +11% | +$3M |
|
72
Novavax
NVAX
$1.28B
| $30.7M | 0.18% |
+275,000
| New | +$30.7M |
|
73
Nuvation Bio
NUVB
$1.33B
| $29.3M | 0.18% |
+2,500,000
| New | +$29.3M |
|
74
Amicus Therapeutics
FOLD
$2.46B
| $28.9M | 0.17% |
+1,250,000
| New | +$28.9M |
|
|
CLVR
75
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
| $28.7M | 0.17% |
+82,603
| New | +$28.7M |
|